| Literature DB >> 33255660 |
Atsushi Kanno1, Eriko Ikeda1, Kozue Ando1, Hiroki Nagai1, Tetsuro Miwata1, Yuki Kawasaki1, Yamato Tada1, Kensuke Yokoyama1, Norikatsu Numao1, Jun Ushio1, Kiichi Tamada1, Alan Kawarai Lefor2, Hironori Yamamoto1.
Abstract
Autoimmune pancreatitis (AIP) is characterized by enlargement of the pancreas and irregular narrowing of the main pancreatic duct. It is often associated with IgG4-related sclerosing cholangitis (IgG4-SC), in which the bile duct narrows. Although characteristic irregular narrowing of the pancreatic duct caused by endoscopic retrograde cholangiopancreatography is noted in AIP, it is difficult to differentiate between localized AIP and pancreatic carcinoma based on imaging of the pancreatic duct. While stenosis of the bile duct in IgG4-SC is characterized by longer-length stenosis than in cholangiocarcinoma, differentiation based on bile duct imaging alone is challenging. Endoscopic ultrasound (EUS) can characterize hypoechoic enlargement of the pancreas or bile duct wall thickening in AIP and IgG4-SC, and diagnosis using elastography and contrast-enhanced EUS are being evaluated. The utility of EUS-guided fine needle aspiration for the histological diagnosis of AIP has been reported and is expected to improve diagnostic performance for AIP. Findings in the bile duct wall from endoscopic retrograde cholangiopancreatography followed by intraductal ultrasonography are useful in differentiating IgG4-SC from cholangiocarcinoma. Diagnoses based on endoscopic ultrasonography play a central role in the diagnosis of AIP.Entities:
Keywords: EUS-guided fine needle aspiration (EUS-FNA); EUS-guided fine needle biopsy (EUS-FNB); International Consensus Diagnostic Criteria (ICDC); autoimmune pancreatitis (AIP); endoscopic ultrasound (EUS)
Year: 2020 PMID: 33255660 PMCID: PMC7760882 DOI: 10.3390/diagnostics10121005
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418